Novavax to raise $200 million through stock offering to fund COVID-19 vaccine
9:24am PDT - June 15th, 2020 novavax stock - ReutersNovavax Inc said on Monday it would raise fresh capital through a $200 million preferred stock offering as it races to develop a vaccine for the new coronavirus, sending its shares up 10.5%.